Showing results (1-10 of 540) with videos related to
Sort By:
Pageof 54
Current Opinion in Endocrinology, Diabetes, and Obesity|July 24, 2009
Combination therapy for obesity and metabolic diseaseKishore M Gadde, David B AllisonExpert Opinion on Pharmacotherapy|April 9, 2009
Combination pharmaceutical therapies for obesityKishore M Gadde, David B AllisonExpert Review of Endocrinology & Metabolism|May 18, 2023
Pharmacotherapy for obesity: recent evolution and implications for cardiovascular risk reductionKevin C Maki, Carol F Kirkpatrick, David B Allison, et al.Current Diabetes Reports|July 5, 2022
Risk of Type 2 Diabetes Among Individuals with Excess Weight: Weight Trajectory EffectsArthur H Owora, David B Allison, Xuan Zhang, et al.Expert Opinion on Pharmacotherapy|February 20, 2014
Current pharmacotherapy for obesity: extrapolation of clinical trials data to practiceKishore M GaddeCurrent Drug Targets. Cardiovascular & Haematological Disorders|March 1, 2006
Endocannabinoid receptor antagonists and other emerging pharma-cological strategies for weight reductionKishore M GaddeArchives of Internal Medicine|November 14, 2012
Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trialKishore M Gadde, Mariko F Kopping, H Ryan Wagner, et al.Lancet (London, England)|April 13, 2011
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trialKishore M Gadde, David B Allison, Donna H Ryan, et al.Postgraduate Medicine|April 2, 2014
Combination phentermine/topiramate for obesity treatment in primary care: a reviewGlen L Xiong, Kishore M GaddeExpert Review of Neurotherapeutics|December 26, 2006
Bupropion for weight reductionKishore M Gadde, Glen L XiongPageof 54